RISK BASED INSPECTION [SCHEDULE M-POINT (33.4)]
![RISK BASED INSPECTION [SCHEDULE M-POINT (33.4)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-33.4-768x1087.jpg)
Risk-Based Inspection (RBI) – Schedule M Point 33.4 verifies “whether all the documents generated during batch production are attached with the BPR” CDSCO Under RBI, this is a high-priority documentation control because missing attachments weaken traceability, investigation quality, and batch…





![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (33.1-33.3)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-WHO-TRS-986-33.1-33.3-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (32.1-32.4)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-WHO-TRS-986-32.1-32.4-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (31.1-31.4)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-WHO-TRS-986-31.1-31.4-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M -POINT (15.6-15.8)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-15.6-15.8-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M -POINT (15.1-15.5)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-15.1-15.5-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (14.16-14.20)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-WHO-TRS-986-14.16-14.20-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (14.10-14.15)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-14.10-14.15-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (14.6-14.9)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-14.6-14.9-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (14.3-14.5)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-14.3-768x1086.jpg)